Rapid Review Quiz: Cancer Overdiagnosis

Elwyn C. Cabebe, MD


April 08, 2022

In 2017, the USPTF reversed the 2012 guidance advising against PSA-based screening in all men. The USPTF endorses individual decision-making for men aged 55-69 years only. Despite the guidance, the researchers found the mean rate of PSA testing increased by 12.5% (95% CI, 1.1%-24.4%). Notably, this included significant increases among men aged 40-54 years and those older than 70 years, for whom screening is not recommended.

Learn more about prostate cancer diagnosis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.